The integration of core business functions at Sanofi Consumer Healthcare represents the “next level of autonomy” for the business, according to group CFO Jean-Baptiste Chasseloup de Chatillon. “As a result, you can expect a much enhanced CHC disclosure, allowing you easy peer comparisons and our team benchmark will be easier and more compelling.” The move came as Sanofi Consumer Healthcare reported a strong end to 2022, with Q4 sales up by 6.6% at constant exchange rates to €1.22bn.
• Source: Sanofi
Sanofi Consumer Healthcare has taken the “next big step” towards becoming a fully standalone business within the French pharma company, according to the unit’s head Julie Van Ongevalle.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
